Proteomics analysis of asthma biomarkers: proxima sub-study

Pierluigi Mauri(Institute of Biomedical Technologies), Giorgio Walter Canonica(Humanitas University), Fabiana Saccheri(Novartis (Italy)), Marta Bartezaghi(Novartis (Italy)), A Riccio(University of Palermo), Rossana Rossi(University of Parma), dario DiSilvestre(Institute of Biomedical Technologies), Laura Rigoni(Novartis (Italy))

Unknown

September 1, 2017

10.1183/1393003.congress-2017.pa1163

Cited by 1

Related Papers

Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision

|Journal of Allergy and Clinical Immunology|2017|2k

Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 Revision

|Journal of Allergy and Clinical Immunology|2010|1.8k

The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria

|Allergy|2018|1.5k

The <scp>EAACI</scp>/<scp>GA</scp><sup>2</sup><scp>LEN</scp>/<scp>EDF</scp>/<scp>WAO</scp> Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update

|Allergy|2014|1.2k

Benefits of omalizumab as add‐on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE

|Allergy|2004|1.1k